AU2009233536A1 - Novel process - Google Patents

Novel process Download PDF

Info

Publication number
AU2009233536A1
AU2009233536A1 AU2009233536A AU2009233536A AU2009233536A1 AU 2009233536 A1 AU2009233536 A1 AU 2009233536A1 AU 2009233536 A AU2009233536 A AU 2009233536A AU 2009233536 A AU2009233536 A AU 2009233536A AU 2009233536 A1 AU2009233536 A1 AU 2009233536A1
Authority
AU
Australia
Prior art keywords
acid
enantiomerically enriched
amino acid
pregabalin
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009233536A
Other languages
English (en)
Inventor
Debashish Datta
Maheshkumar Gadakar
Vinayak Gore
Viraj Mankar
Kiran Pokharkar
Sneha Wavhal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of AU2009233536A1 publication Critical patent/AU2009233536A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/34—Preparation of optical isomers by separation of optical isomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2009233536A 2008-04-04 2009-04-02 Novel process Abandoned AU2009233536A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN679/KOL/2008 2008-04-04
IN679KO2008 2008-04-04
PCT/GB2009/050326 WO2009122215A1 (en) 2008-04-04 2009-04-02 Novel process

Publications (1)

Publication Number Publication Date
AU2009233536A1 true AU2009233536A1 (en) 2009-10-08

Family

ID=40674128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009233536A Abandoned AU2009233536A1 (en) 2008-04-04 2009-04-02 Novel process

Country Status (8)

Country Link
US (1) US20110124909A1 (cg-RX-API-DMAC7.html)
EP (1) EP2262761A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011516459A (cg-RX-API-DMAC7.html)
CN (1) CN102089273A (cg-RX-API-DMAC7.html)
AU (1) AU2009233536A1 (cg-RX-API-DMAC7.html)
CA (1) CA2719892A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ588894A (cg-RX-API-DMAC7.html)
WO (1) WO2009122215A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010110361A1 (ja) 2009-03-26 2010-09-30 第一三共株式会社 二環性γ-アミノ酸誘導体の製造方法
HUP1000186A2 (en) 2010-04-08 2011-10-28 Richter Gedeon Nyrt Novel industrial process of preparing (s)-(+) pregabalin
JP2013539470A (ja) * 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
EP2527319A1 (en) * 2011-05-24 2012-11-28 Laboratorios Del. Dr. Esteve, S.A. Crystalline forms of pregabalin and co-formers in the treatment of pain
JP6482465B2 (ja) 2012-11-07 2019-03-13 ハイカル リミテッド プレガバリンの調製方法
CN105085290A (zh) * 2015-08-18 2015-11-25 太仓运通生物化工有限公司 一种合成普瑞巴林的方法
CN105348124A (zh) * 2015-11-26 2016-02-24 太仓运通生物化工有限公司 一种以氧代吡咯烷为中间体合成普瑞巴林的方法
CN108456144A (zh) * 2017-11-03 2018-08-28 乳源东阳光药业有限公司 一种小粒径晶状普瑞巴林、组合物及其制备工艺
CN113801031B (zh) * 2021-10-26 2023-12-26 浙江华海药业股份有限公司 一种普瑞巴林的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US20060270871A1 (en) * 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
EP1736462A1 (en) * 2005-06-22 2006-12-27 Sandoz AG Recovery of optically active tartaric acid resolving agents
WO2008117305A2 (en) * 2007-03-28 2008-10-02 Glenmark Pharmaceuticals Limited A novel process for preparing pregabalin and its acid addition salts
WO2008138874A1 (en) * 2007-05-09 2008-11-20 Chemo Ibérica, S.A. Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
US8168828B2 (en) * 2007-06-25 2012-05-01 Msn Laboratories, Limited Process for the preparation of pregabalin
WO2009044409A2 (en) * 2007-10-01 2009-04-09 Natco Pharma Limited Novel resolution process for pregabalin

Also Published As

Publication number Publication date
CA2719892A1 (en) 2009-10-08
NZ588894A (en) 2012-12-21
CN102089273A (zh) 2011-06-08
US20110124909A1 (en) 2011-05-26
WO2009122215A1 (en) 2009-10-08
JP2011516459A (ja) 2011-05-26
EP2262761A1 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
CA2719892A1 (en) Novel process
US4198524A (en) Optically active amino acid-mandelic acid complexes
CA1338672C (en) Process for the synthesis of the levodopa
US7763749B2 (en) Method for the preparation of Pregabalin and salts thereof
WO2009053446A2 (en) Pregabalin intermediates and process for preparing them and pregabalin
JP2009120611A (ja) エナンチオマーとして純粋なアゼチジン−2−カルボン酸の改良された製造方法
JP2011516459A5 (cg-RX-API-DMAC7.html)
US6051734A (en) Process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
EP1224161B1 (en) Nitroxy derivatives of (r) and (s)-carnitine
JP2009108079A (ja) エナンチオマーに富むn−アシルアゼチジン−2−カルボン酸の製造方法
US20080015385A1 (en) Preparation of (S)-pregabalin-nitrile
JPH02304049A (ja) R(+)―アミノカルニチンおよびs(―)―アミノカルニチンの製造方法
KR100838922B1 (ko) 알플러스알파-리포산의 제조 방법
EP1879854B1 (en) Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
CN102656139B (zh) 制造l-肉毒碱的方法
US6479702B1 (en) 3-amino-1-indanole, method of synthesizing the same and method of optical resolution
WO2009125427A2 (en) Process for preparing (s)-3-(aminomethyl)-5-methylhexanoic acid
TWI485126B (zh) 製造l-肉鹼的方法
MXPA98008788A (en) Improved process for the production of azetidin-2- carboxylic acid enantiomerically p
JPH07110841B2 (ja) アミノ酸複合体
HK1175166B (en) Methods for the production of l-carnitine
WO1999058493A2 (en) Process for the preparation of optically pure phenylalanine

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application